Anzeige
Mehr »
Login
Donnerstag, 25.02.2021 Börsentäglich über 12.000 News von 656 internationalen Medien
Adhoc-Meldung: Eine ganz große Überraschung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1H65A ISIN: NL0010391025 Ticker-Symbol: PHGN 
Tradegate
25.02.21
15:30 Uhr
1,128 Euro
-0,010
-0,84 %
Branche
Biotechnologie
Aktienmarkt
AMX
1-Jahres-Chart
PHARMING GROUP NV Chart 1 Jahr
5-Tage-Chart
PHARMING GROUP NV 5-Tage-Chart
RealtimeGeldBriefZeit
1,1041,12417:49
1,1101,11817:51

Aktuelle News zur PHARMING Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
PHARMING Aktie jetzt für 0€ handeln
23.12.20Pharming Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq Listed ADSs368Costs for conversion of Ordinary Shares into ADS's waived by JP Morgan Chase for initial four weeks after today LEIDEN, Netherlands, Dec. 22, 2020 /PRNewswire/ -- Pharming Group...
► Artikel lesen
23.12.20Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol "PHAR"343U.S. SEC declares registration statements effective Each ADS represents 10 ordinary shares The Company's ordinary shares continue to trade on Euronext Amsterdam No new shares...
► Artikel lesen
22.12.20Pharming Group Is A COVID-19 Hedge28
21.12.20Pharming Group Lines Up U.S. Offering Plan22
21.12.20Pharming Group N.V. - 8-A12B, Registration of securities14
17.12.20Pharming Group N.V. - F-1/A, Registration statement for certain foreign private issuers19
11.12.20Pharming Reports on Extraordinary General Meeting of Shareholders290LEIDEN, Netherlands, Dec. 11, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces that at its Extraordinary General Meeting of shareholders...
► Artikel lesen
10.12.20Pharming announces enrolment of first patient in US clinical trial for the treatment of COVID-19 with RUCONEST509Highlights: First patient treated in second clinical trial globally investigating the use of RUCONEST to prevent severe SARS-CoV-2 infections in hospitalised patients with confirmed...
► Artikel lesen
26.11.20Pharming Group Publicly Files Registration Statement with the U.S. SEC to Facilitate Listing of ADSs Representing Ordinary Shares on Nasdaq Global Market398LEIDEN, The Netherlands, 26 November 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) ("Pharming" or the "Company"), a global, commercial stage biopharmaceutical company...
► Artikel lesen
25.11.20Pharming Group N.V. - F-1, Registration statement for certain foreign private issuers4
23.11.20Juergen Ernst to retire from Pharming's Board of Supervisory Directors after more than 11 years of distinguished service368Ms. Debora Jorn named as new Vice-Chair LEIDEN, Netherlands, Nov. 23, 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) announces that its Vice-Chair, Juergen Ernst...
► Artikel lesen
19.11.20Pharming announces commitment to build a new downstream manufacturing facility for RUCONEST416LEIDEN, The Netherlands, Nov. 19, 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) announces it has committed to building a new facility to expand the Company's downstream...
► Artikel lesen
13.11.20Pharming FAQ: Was Sie über Fake-Webseiten wissen müssen9
09.11.20Pharming appoints Jeroen Wakkerman as Chief Financial Officer331LEIDEN, The Netherlands, Nov. 9, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces the appointment of Jeroen Wakkerman as Chief...
► Artikel lesen
03.11.20Pharming Group Is Expanding Production Capacity For Their COVID-19 Treatment26
29.10.20Pharming Group reports financial results for the first nine months of 2020398Continued solid performance and strong recovery of sales in Q3 2020 Delivered 9.2% increase in revenues, 19.8% increase in operating profit and 6.4% increase in net profit (59% increase...
► Artikel lesen
29.10.20Pharming convenes Extraordinary General Meeting of shareholders269LEIDEN, Netherlands, Oct. 29, 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) today announces it will hold an Extraordinary General Meeting (EGM) of Shareholders on Friday...
► Artikel lesen
22.10.20Pharming's APDS drug scores EU orphan status9
21.10.20Pharming receives Orphan Drug Designation from the European Commission for leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS)291- Leniolisib is in a phase II/III registration-enabling study for the treatment of APDS, an ultra-rare and debilitating disease with no approved treatment - If approved, the drug is...
► Artikel lesen
17.08.20Pharming announces the publication of data from a compassionate use programme of RUCONEST in COVID-19 patients in a peer-reviewed journal450LEIDEN, Netherlands, Aug. 17, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) today announces the publication of data in the peer-reviewed...
► Artikel lesen
Seite:  Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
41,1,4